magnifying glass
logo for Axon Neuroscience

Axon Neuroscience

Business Services · Slovakia · 31 Employees

Get Full Access

Who is Axon Neuroscience

Axon Neuroscience is an industry leading, clinical stage biotech company and an innovator in the development of peptide vaccines against so-far incurable brain diseases. The company was founded in 1999 and now has the single biggest team in the world dedicated exclusively to peptide vaccine development for treating Alzheimer's Disease. The work of the Axon team is regularly published in top-tier scientific journals and publications, including Lancet Neurology and Neurology. Axon's lead vaccine AADvac1 is the most clinically-advanced tau therapy in development for treating and preventing Alzheimer's Disease. In late 2019, Axon successfully completed a Phase 2 clinical trial in almost 200 Alzheimer's patients, which revealed excellent safety, immunogenicity and efficacy. The evidence from its clinical trials on Alzheimer's disease proved its peptide-based vaccine platform to be very safe and well-tolerated. Over 80% of the treated Alzheimer's patients demonstrated an exceptional immune response and generated a robust quantity of antibodies. The therapy was able to significantly slow down the process of neurodegeneration in treated patients by almost 60%. Axon's extensive knowledge in producing safe and immunogenic vaccines and well-established scalable technology allowed it to move very quickly in creating its novel peptide vaccine against COVID-19.Read More



Dvorákovo Nábrežie 10, Bratislava, 811 02, Slovakia
Phone Number

Phone Number:

+421 2/209 216 20


$6 Million
Axon Neuroscience's Social Media
SIC Code 87,873
NAICS Code 541,541713
Popular Searches:

AXON Neuroscience


AXON Neuroscience and MRC Technology

AXON Neurosciences

Illustration of an envelope

Axon Neuroscience Company Metrics

Company Insights
Employee Growth Rate

'21 - Q1


'21 - Q2


Axon Neuroscience's Tech Stack

Google Workspace (formerly G Suite)



Facebook Analytics



Twitter Cards





See more technologies

Axon Neuroscience News & Media

Nature Aging publishes phase II results for AADvac1, a first-in-man Alzheimer's tau vaccine developed by Axon Neuroscience

NEW YORK, June 14, 2021 /PRNewswire/ -- AXON NEUROSCIENCE SE ("Axon"), a clinical stage biotech company at the forefront of treating and preventing Alzheimer's disease announced today the publication in Nature Aging of results from its completed Phase II study ADAMANT evaluating its tau...

Axon Neuroscience to launch world's first crowdfunded vaccine against COVID-19

- The world's first and only crowdfunded vaccine against COVID-19 - Investment opportunities beginning in October 2020 from - Key pre-clinical study demonstrated that the ACvac1 vaccine can block the live SARS CoV-2 virus from replicating - Plan to enter phase I...

Axon Announces Positive Pre-Clinical Results for its Peptide Vaccine (ACvac1) Against Novel Coronavirus

- The new peptide vaccine ACvac1 generated a high titer of antibodies in vaccinated mice. - The generated antibodies completely neutralised the live SARS-CoV-2 virus. - No signs of off-target effects or adverse reactions were observed in the vaccinated mice. - These results put Axon in a...
Subscribe to "Axon Neuroscience" News

Frequently Asked Questions regarding Axon Neuroscience

Where are Axon Neuroscience’s headquarters?

Axon Neuroscience’s headquarters are in Dvorákovo Nábrežie 10, Bratislava, 811 02, Slovakia

What is Axon Neuroscience’s phone number?

Axon Neuroscience’s phone number is +421 2/209 216 20

What is Axon Neuroscience’s official website?

Axon Neuroscience’s official website is

What is Axon Neuroscience’s Revenue?

Axon Neuroscience’s revenue is $6 Million

What is Axon Neuroscience’s SIC code?

Axon Neuroscience’s SIC: 87,873

What is Axon Neuroscience’s NAICS code?

Axon Neuroscience’s NAICS: 541,541713

How many employees are working in Axon Neuroscience?

Axon Neuroscience has 31 employees

What is Axon Neuroscience’s industry?

Axon Neuroscience is in the industry of: Business Services, Research & Development

What is Axon Neuroscience's tech stack?

The technologies that are used by Axon Neuroscience are: Google Workspace (formerly G Suite), Facebook Analytics, Twitter Cards, DigiCert

See more information about Axon Neuroscience
4.4/5 on G2 Crowd